Syndax Pharmaceuticals, Inc. (SNDX)
19.57
-0.08
(-0.41%)
USD |
NASDAQ |
Aug 24, 16:00
19.70
+0.13
(+0.66%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Liabilities (Quarterly) : 688.55M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 688.55M |
| March 31, 2026 | 431.05M |
| December 31, 2025 | 465.08M |
| September 30, 2025 | 436.36M |
| June 30, 2025 | 438.72M |
| March 31, 2025 | 425.65M |
| December 31, 2024 | 436.69M |
| September 30, 2024 | 59.38M |
| June 30, 2024 | 42.61M |
| March 31, 2024 | 51.14M |
| December 31, 2023 | 58.68M |
| September 30, 2023 | 40.04M |
| June 30, 2023 | 31.30M |
| March 31, 2023 | 24.32M |
| December 31, 2022 | 29.79M |
| September 30, 2022 | 21.58M |
| June 30, 2022 | 44.50M |
| March 31, 2022 | 47.67M |
| December 31, 2021 | 41.29M |
| September 30, 2021 | 40.50M |
| June 30, 2021 | 48.50M |
| March 31, 2021 | 51.47M |
| December 31, 2020 | 48.42M |
| September 30, 2020 | 47.33M |
| June 30, 2020 | 44.98M |
| Date | Value |
|---|---|
| March 31, 2020 | 51.65M |
| December 31, 2019 | 31.92M |
| September 30, 2019 | 32.34M |
| June 30, 2019 | 32.12M |
| March 31, 2019 | 30.77M |
| December 31, 2018 | 30.89M |
| September 30, 2018 | 32.19M |
| June 30, 2018 | 35.02M |
| March 31, 2018 | 33.01M |
| December 31, 2017 | 32.87M |
| September 30, 2017 | 27.78M |
| June 30, 2017 | 25.33M |
| March 31, 2017 | 25.05M |
| December 31, 2016 | 24.87M |
| September 30, 2016 | 23.90M |
| June 30, 2016 | 21.62M |
| March 31, 2016 | 22.41M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | 14.90M |
| June 30, 2014 | 5.35M |
| March 31, 2014 | 4.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | 113.58M |
| Kura Oncology, Inc. | 539.36M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 703.65M |
| Shareholders Equity (Quarterly) | 15.10M |
| Debt to Equity Ratio | 39.03 |
| Current Ratio | 6.772 |
| Net Debt Paydown Yield | -2.50% |